Ecobot Earns 2022 EBJ Business Achievement Award
ASHEVILLE, N.C., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Ecobot, the premier digital solution for mandatory pre-construction assessments, has received a 2022...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 19:50
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 19:46
Kura Oncology to Report Fourth Quarter and Full Year 2022
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 19:31
Intellia Therapeutics to Hold Conference Call to Discuss
CAMBRIDGE, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 19:05
Decibel Therapeutics to Present at the Upcoming SVB
BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 19:03
Shattuck Labs to Report Fourth-Quarter and Full-Year 2022
AUSTIN, TX & DURHAM, NC, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 12:03
WatchGuard Launches New Line of Firewall Products to
Powered by WatchGuard’s Unified Security Platform® architecture, new Fireboxes deliver enhanced performance and added security capabilities that MSPs and...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 06:34
GA-ASI Partners With Divergent Technologies, Inc.
UAS Leader Integrates DAPS Digital Manufacturing Process...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 05:26
Emergent BioSolutions Reports FDA Advisory Committees’
If approved by the FDA, NARCAN Nasal Spray will be the first 4 mg naloxone nasal spray switched from prescription status to over-the-counter use ...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 04:07
Atea Pharmaceuticals to Present Data on Bemnifosbuvir Drug
BOSTON, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 01:51
Chris-Craft Debuts New Calypso 32 at the Miami
Calypso 32 & Launch 25 GTe Press Conference Chris-Craft Booth -MB1966 2/15/23- 1:30pm EST SARASOTA, Fla., Feb. 15, 2023 (GLOBE NEWSWIRE) --...
